Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Village health workers cut deaths in remote indian tribes

NCT ID NCT07436104

Disease control Sponsor: MAHAN Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This large study in rural India trained village health workers to diagnose and treat common illnesses like high blood pressure, diarrhea, pneumonia, malaria, asthma, and COPD. Over 72,000 adults aged 16-60 from 80 tribal villages took part. The goal was to reduce deaths by at least 30% in this age group. The approach combined medicine, education, and hospital referrals.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Trained village health workers providing medicines (amlodipine, ORS, norfloxacin, chloroquine, azithromycin, salbutamol) and behavior change counseling
What this could lead to
If successful, this approach could offer a low-cost model to reduce premature deaths from common diseases in remote areas.
What could go wrong
The trial is completed and results may not apply to other regions or populations. The intervention combines many elements, so it's unclear which part worked best.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

72,564 people

The number who actually took part.

Started

Jan 2004

Finished

Aug 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All individuals aged 16-60 years residing in the study villages who gave written informed con-sent/assent were included as participants. * De-facto (only in study village or hospital) and de-jure methods (outside study villages) were used during research phase. * De-facto method for replication phase. Exclusion Criteria: * Out-migrants \>6 months, were excluded from analysis.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma (diagnosis) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

asthma cardiovascular disorder chronic diarrheal disease chronic obstructive pulmonary disease COPD, severe early onset diarrheal disease disease hypertensive disorder malaria pneumonia tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Asthma (diagnosis) COPD Diarrhea Diarrhea chronic Hypertension (HTN) Malaria fever Pneumonia

Contacts and locations

Locations

  • Mahatma Gandhi Tribal Hospital Karmgram Utavali Dharni Amaravati

    Amravati, Maharashtra, 444702, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.